What Researchers Did
Researchers conducted the first comprehensive review of hyperbaric oxygen therapy (HBOT) for various ocular indications.
What They Found
The review identified nine ocular conditions for which HBOT is recommended, including central retinal artery occlusion and carbon monoxide poisoning with visual sequelae. Additionally, 15 other ocular disorders, such as ischemic optic neuropathy and radiation retinopathy, were found to potentially benefit from HBOT.
What This Means for Canadian Patients
Canadian patients with specific eye conditions, such as central retinal artery occlusion or radiation optic neuropathy, may find HBOT to be a beneficial treatment option. This therapy could potentially help preserve or improve vision for those suffering from these and other related ocular disorders.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review, the study's findings are dependent on the quality and completeness of the existing literature it synthesized.